Pharma

Developing a single approved drug costs an average of $2.6 billion when the full portfolio of failures is factored in. That figure, widely cited from research in the Journal of Health Economics, is not primarily a chemistry problem or a clinical science problem. It is, in large part, a data governance problem—and the pharmaceutical industry […]